That quote in our headline comes from Bret Jensen, who runs the Blue Chip Gems newsletter put out by Investors Alley (he also has a Biotech Gems letter and a Small Cap Gems letter, with sector focus that you can probably guess at by their titles). We’ve looked at a couple of stocks he has […]
Articles
- Most Relevant
- Most Recent
That’s the headline for the latest ad from David Dittman, who inherited leadership of the Canadian Edge newsletter when Roger Conrad left for greener pastures. And I was intrigued enough to take a look — not least because he’s touting some ancillary stocks that benefit indirectly from oil money… but also because, unlike every other […]
This ad has been running again and generating a lot of questions from Gumshoe readers, so we’re re-posting the answer here. The article below has not been updated or revised since it was published on July 20, 2015, other than an update to the Irregulars “Quick Take” box and an updated disclosure at the bottom […]
Ian King is out with another promo for his Automatic Fortunes newsletter published by Banyan Hill, and like most such “presentations” he makes some huge predictions to tantalize you with dreams of wealth. And they’re also (again) being a bit sneaky with the offer they’re making, so make sure to read the fine print if […]
I was looking into a couple little eensy teensy microcap stocks that are being touted this week, and I just didn’t have the heart to write about them for you — I do cover microcaps from time to time, but I know that most of you are too experienced and sober to be investing in […]
We’ve got a big new cryptocurrency-related pitch to look at for you today, and since it’s from Ray Blanco at Agora’s Breakthrough Technology Alert, one of the most heavily-marketed newsletters around, you’ll probably see the ad soon if you haven’t already. It’s all about what Ray Blanco calls “The Stockchain” … which is basically the […]
Many Gumshoe readers wanted me to follow up on yesterday’s marijuana article right away, identifying the other two stocks hinted at in the ads for Nick Giambruno’s Crisis Investing… and we aim to please, so let’s jump right into it. If you missed part one, you can check that out here — the overriding argument […]
I haven’t written about a Frank Curzio teaser for a while, so when a few readers asked about his new “$60 billion paycheck” pitch I thought I’d take a look for you… this came as an ad for his Curzio Research Advisory, which is Frank’s “entry level” newsletter (he’s offering it at $79/year currently), and […]
This one already has a little discussion going among some of our intrepid Gumshoe Irregulars, and at least one of them has ID’d the right stock … but I’ve been asked to weigh in, so I’ll give it the full treatment today. The ad is for Michael Robinson’s Radical Technology Profits, which comes from Money […]
We’ve gotten a bunch of questions recently about this pitch from Nathan Slaughter about gas to liquids technology and the “death of OPEC,” so I’m sharing an excerpt from the Friday File article about this teaser that we published a little over three weeks ago for the Irregulars. Don’t worry, it’s the meat of the […]
Your friendly neighborhood Gumshoe is still working feverishly on the new and improved StockGumshoe.com that we hope to be introducing in the weeks to come, so today we’re sharing an older article that originally appeared in the Irregulars-only Friday File. I’ve shortened the article to remove some of my blather, but it has not been […]
On a day when the Carlyle Group (CG) is making headlines for their IPO, which was generally received with a “meh” by Wall Street (priced slightly below the range, no pop on the IPO), why not take a look at a different private equity-type stock that’s apparently paying a much higher dividend? Or at least, […]
This is the intro that was catching the attention of Gumshoe readers over the weekend, from an ad for Ray Blanco’s Breakthrough Technology Alert ($2,000/yr, no refunds): “THE WORLD’S FASTEST FORTUNE “Tiny company to hit $100 billion valuation faster than any other biotech in history… “Here’s how you can get FREE SHARES* — for potential […]
“The next MegaTrend is here and ready to make a bundle from it.I just spent six months researching it, and I’ve dug out what I think is my greatest stock pick ever. “My only concern is that this company gets bought out in the next six months. “And that I miss out on its long […]
This is all hush-hush, you understand — I’m taking terrible risks by just writing to you today. And my intrepid readers, members of the resistance, have also pushed the limits in sharing this news. The ad makes this very clear — it came with the subject line, “WARNING! Do Not Share, Do Not Forward” But […]
Thoughts from Myron–Elements and EnergyEd. note: Here is the third article from longtime reader Myron Martin. Again, we’d love to hear what you think of this feature in the comments section. Myron has agreed to our trading restrictions (he won’t trade the stocks he mentions for three days), but we have not reviewed, approved or screened his stocks or […]
Before I get churning with this week’s Friday File, I want to take the opportunity to thank you, the Irregulars — and particularly the several new members we’ve had join up as Irregulars in the last few weeks — welcome to the club! Stock Gumshoe has always tried to balance how we do things, offering […]
I’ll be traveling for most of the next week, so we’re getting this Idea of the Month note out to you on Thursday night/Friday morning, a bit early. There will not be a Friday File or much else in the way of new content at Stock Gumshoe next week, but I will provide at least […]
What do I think? That’s what a lot of readers are asking during these volatile days… and there is, of course, no easy answer. My thoughts are all over the place, so today’s Friday File musings are going to run the gamut. Tesla (TSLA) is a good example of how the market is treating investors […]
We’re just about shut down here at Stock Gumshoe HQ for the market holiday today, but I do have some updated thoughts and musings for you about a few of the companies I own and write about with some regularity: Leucadia (LUK), Medical Properties Trust (MPW), and Fosun (FOSUF). And I should also update you […]
I always like reading Chris Mayer’s stuff — he often presents at the Value Investing Congress, he seems to be an interesting and low-key guy in person, and the ideas that are pitched by his various newsletters at Agora often catch my eye. They don’t always work out, of course, but every once in a […]
I was looking at the photonics chip teaser from Agora Financial again recently, since it’s being heavily teased again to advertise for subscribers to Technology Profits Confidential and the questions are rolling in (you can see that here, I just re-posted it to help answer some of those questions)… …and since that teaser pick, Infinera […]
Travis any thoughts on the recent teaser from Kent Moors and his publisher Mike Ward: 9,500 times more powerful than oil… And 100 times cheaper… This often-ignored fuel has quietly become an irreplaceable component of the global energy mix. As an advisor to 27 world governments, my colleague, Dr. Kent Moors has told us: Nearly […]
I’ve got a big ol’ pile of updates and thoughts about a dozen or so companies to get to, but we’re going to start with a teaser solution today. Paul Mampilly of Agora Financial’s FDA Trader apparently sent around a teaser note to his own subscribers (I say “apparently” because I’ve only seen the cut-and-paste […]
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He chooses his own topics, and his words and opinions are his own.] Careful analysis of Ebola sequences in infected Africans confirms this: the entire present Ebola outbreak emerged as a consequence of one boy in Meliandoua, in eastern Guinea, eating a […]
TECHNICAL ANALYSIS OF THE FINANCIAL MARKETS was mentioned weeks ago by another Irregular as an excellent reference for technical analysis (TA). ( I apologize for not being able to give him credit, but I could not find his name by searching SGS.) I bought the book because of his recommendation and because the book has […]
Matt Badiali and the folks at Stansberry Research are very skilled at using the names of politicians to inspire visceral reactions in readers and get them to read their ads or listen to their sales pitch presentations. Which is, of course, the point — and it doesn’t even really matter which politician’s name they use, […]
Tweeka Tiwari’s Mega Trends, is touting the ”fact” that there is an FDA program to rush development of a vaccine for the latest (more virulent) strain of Ebola. He names three companies: BCRX NLNK TKMR Any thoughts Dr Kss?
Here is the latest one I’ve received: 4 minutes to prove $7million profit, 96.79% accurate 4 Minutes To Prove It’s Real – Over $7 Million in profits and 96.79% Accurate! Lifetime Income System WOW… That’s one heck of an opening line! And in this video you’ll get to examine actual account statements proving the reality […]
Hi Guys, Anyone here is subscribed to SeekingAlpha PRO? Is it useful and worth the pennies? Plus who knows the best place to look for investment advice for the Asian market (China mainland, HongKong, Singapore, etc..)? Thanks a lot! Ruben
This appears to be the “hot” story of the day, given the number of alert Gumshoe readers who have been forwarding it along (you can always submit your teasers, too, or forward them to ILoveStockSpam[at]gmail.com — the more the merrier!) — it’s from Wall Street Daily and is selling their Publisher’s Series as a quarterly offering […]
Advisory that recommends specific trades to generate income by selling options.
During the last few days when I was traveling to and reporting from the Value Investing Congress for the Irregulars (some great presentations, by the way, my notes from day one and day two are up now and I’m hoping to get some more thinking time in regarding these ideas soon), the most-requested teaser for […]
Teeka Tiwari teasers wash up on the shores of Gumshoe island every few months, though we don’t cover them all that often because he hasn’t done a lot of teasing of individual stock ideas (he has more frequently, if memory serves, pitched his trading “systems”). It looks like Tiwari’s Mega Trends is now being published […]
Trend-driven investing recommendations from Teeka Tiwari. Newsletter has closed.
The Casey Energy Report is pretty pricey these days ($995/year), and so it gets quite a bit of reader attention when they hint around about a hot new idea of theirs. And so it was that your friendly neighborhood Gumshoe got a nice, full mailbox this morning with folks forwarding a story that the Casey […]
August 15, 2014 Dear Reader, Right now, a unique life-saving effort is underway in a sub-niche of the financial markets. If you choose to invest in this ”campaign” – as I’ll outline in a moment – your reward will be twofold… First, you’ll get the deep satisfaction of knowing your investment helped save lives – […]
First, I should tell you that this is bad for you. This searching for stocks that double in a day. Seeking such instant gratification in investing is like drinking three beers for breakfast every day because you’re thinking you might run into a friendly Brazilian model on the subway and you want to be “loose” […]
Dear Reader, Today I rip the cover off my company’s secret weapon. I call him the “reluctant millionaire maker.” Talk about operating undercover. This guy’s living it. He craves privacy… he’s been lying low for the past decade… yet his Wikipedia page has 47 footnotes. What gives? For a long time, he has run in […]
That’s the headline for the latest ad from David Dittman, who inherited leadership of the Canadian Edge newsletter when Roger Conrad left for greener pastures. And I was intrigued enough to take a look — not least because he’s touting some ancillary stocks that benefit indirectly from oil money… but also because, unlike every other […]